Approval · Notice of Compliance 1669 · 1999
SUPRANE: Notice of Compliance 1669
Issued December 31, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1669
- Date
- December 31, 1999
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Inhalation anaesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPRANE | 02227428 | Marketed |
Medicinal ingredients
- DESFLURANE 1 ML per ML